Alisertib (MLN8237)

For research use only.

Catalog No.S1133

254 publications

Alisertib (MLN8237) Chemical Structure

CAS No. 1028486-01-2

Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a cell-free assay. It has >200-fold higher selectivity for Aurora A than Aurora B. Alisertib induces cell cycle arrest, apoptosis and autophagy. Phase 3.

Size Price Stock Quantity  
10mM (1mL in DMSO) USD 168 In stock
USD 120 In stock
USD 210 In stock
USD 670 In stock
USD 1770 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Selleck's Alisertib (MLN8237) has been cited by 254 publications

Purity & Quality Control

Choose Selective Aurora Kinase Inhibitors

Biological Activity

Description Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM in a cell-free assay. It has >200-fold higher selectivity for Aurora A than Aurora B. Alisertib induces cell cycle arrest, apoptosis and autophagy. Phase 3.
Features First orally available inhibitor of Aurora A.
Targets
Aurora A [1]
(Cell-free assay)
1.2 nM
In vitro

MLN8237 shows >200-fold higher selectivity for Aurora A than the structurally related Aurora B with an IC50 of 396.5 nM, and does not have any significant activity against 205 other kinases. [1] MLN8237 (0.5 μM) treatment inhibits the phosphorylation of Aurora A in MM1.S and OPM1 cells, without affecting the Aurora B mediated histone H3 phosphorylation. MLN8237 significantly inhibits cell proliferation in multiple myeloma (MM) cell lines with IC50 values of 0.003-1.71 μM. MLN8237 displays more potent anti-proliferation activity against primary MM cells and MM cell lines in the presence of BM stroma cells, as well as IL-6 and IGF-1 than against MM cells alone. MLN8237 (0.5 μM) induces 2- to 6-fold increase in G2/M phase in primary MM cells and cell lines, as well as significant apoptosis and senescence, involving the up-regulation of p53, p21 and p27, as well as PARP, caspase 3, and caspase 9 cleavage. In addition, MLN8237 shows strong synergistic anti-MM effect with dexamethasone, as well as additive effect with doxorubicin and bortezomib. [2] MLN8237 (0.5 μM) treatment causes the inhibition of colony formation of FLO-1, OE19, and OE33 esophageal adenocarinoma cell lines, and induces a significant increase in the percentage of polyploid cells, and subsequently an increase in the percentage of cells in the sub-G1 phase, which can be further enhanced in combination with cisplatin (2.5 μM), involving the higher induction of TAp73β, PUMA, NOXA, cleaved caspase-3, and cleaved PARP as compared with a single-agent treatment. [3]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
HCT116 MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGXPbXcxNjVizszN M3jueFczKGh? MVLEUXNQ NV7sNpgzUUN3ME2wMlA1KM7:TR?= MVW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjF|Nk[4OEc,OjZzM{[2PFQ9N2F-
LS174T MmftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M{\nTlAvPSEQvF2= MkXPO|IhcA>? MVrEUXNQ Ml7GTWM2OD1yLkC1JO69VQ>? NEPxUlQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkGzOlY5PCd-Mk[xN|Y3QDR:L3G+
T84 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUjhWWxDOC53IN88US=> MW[3NkBp MmPVSG1UVw>? NH33[IFKSzVyPUCuNFkh|ryP MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjF|Nk[4OEc,OjZzM{[2PFQ9N2F-
LS180 NFPwSnlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXu1OVB1OC53IN88US=> MXG3NkBp MoTnSG1UVw>? M4PwNmlEPTB;MTFOwG0> Ml:wQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzM{[2PFQoRjJ4MUO2Olg1RC:jPh?=
SW948 MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M{mye|AvPSEQvF2= NHPLd4U4OiCq NEHiZWlFVVOR M1vMNmlEPTB;MTFOwG0> Mm\PQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjZzM{[2PFQoRjJ4MUO2Olg1RC:jPh?=
HCT15 MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MoXjNE42KM7:TR?= NH7vZmI4OiCq NIO1dW9FVVOR MmexTWM2ODxyLkSg{txO MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjF|Nk[4OEc,OjZzM{[2PFQ9N2F-
DLD-1 M2TrV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYPSfmNvOC53IN88US=> MXG3NkBp NVqwWY1kTE2VTx?= NYPOZph{UUN3MEywMlgh|ryP M363T|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MUO2Olg1Lz5{NkGzOlY5PDxxYU6=
MIP-101 MlTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NGqxUFkxNjVizszN NFHVTIw4OiCq NF7JcZZFVVOR NH3WOmtKSzVyPUGg{txO NH;zVlA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkGzOlY5PCd-Mk[xN|Y3QDR:L3G+
SNU1544 M3ywXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M1jKb|AvPSEQvF2= M4TYNFczKGh? NX;TRok6TE2VTx?= MnXMTWM2OD1zIN88US=> NUnzem8{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[xN|Y3QDRpPkK2NVM3Pjh2PD;hQi=>
OCI-Ly10 NFK5SoVEgXSxdH;4bYMhSXO|YYm= MWS3NkBp M4G3TGROW09? MX;JR|UxRTBwMEW4JO69VQ>? MoPRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6N{izN|EoRjJ3OEe4N|MyRC:jPh?=
SU-DHL2 NGrnXmhEgXSxdH;4bYMhSXO|YYm= NHLF[|I4OiCq NET3VFJFVVOR NULIfYM3UUN3ME2wMlAyKM7:TR?= M3nhblxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEe4N|MyLz5{NUi3PFM{OTxxYU6=
OCI-LY7 M1LlcWN6fG:2b4jpZ{BCe3OjeR?= Ml;FO|IhcA>? M3LVVmROW09? NFK4c4NKSzVyPUCuNFgyKM7:TR?= MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
SU-DHL6 Ml;VR5l1d3SxeHnjJGF{e2G7 MlK1O|IhcA>? NY\BOIJrTE2VTx?= MojUTWM2OD1yLkS4NkDPxE1? NYTHT5VkRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
Jeko-1 MnzWR5l1d3SxeHnjJGF{e2G7 MVG3NkBp MWPEUXNQ NW\3d4ZrUUN3ME2wMlAzQSEQvF2= MnHVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6N{izN|EoRjJ3OEe4N|MyRC:jPh?=
JVM-2 NHnCR4REgXSxdH;4bYMhSXO|YYm= MmH1O|IhcA>? M2PtOGROW09? MnzaTWM2OD1yLkCxJO69VQ>? NYjwTm9sRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
Rec-1 NXHZXnBxS3m2b4TvfIlkKEG|c3H5 M{LsV|czKGh? M1TMWGROW09? M{D6ZmlEPTB;MD6wPFch|ryP NVjxSYdFRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
Z-138 MXTDfZRwfG:6aXOgRZN{[Xl? MXW3NkBp M4jHTmROW09? NHnOd21KSzVyPUCuNFE{KM7:TR?= NV3NSYxzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
H9 MXLDfZRwfG:6aXOgRZN{[Xl? MnHvO|IhcA>? MkTCSG1UVw>? NFPVb3hKSzVyPUCuOkDPxE1? Mo\LQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6N{izN|EoRjJ3OEe4N|MyRC:jPh?=
HH MnfCR5l1d3SxeHnjJGF{e2G7 NEPj[oo4OiCq MnrlSG1UVw>? NGTofW9KSzVyPUCuO{DPxE1? NGGyOZE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUi3PFM{OSd-MkW4O|g{OzF:L3G+
DND41 Ml\yR5l1d3SxeHnjJGF{e2G7 MnPvO|IhcA>? M2qzZmROW09? NIjqcZpKSzVyPUCuNUDPxE1? NH\ET|k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUi3PFM{OSd-MkW4O|g{OzF:L3G+
CCL119 M2rQbWN6fG:2b4jpZ{BCe3OjeR?= MUO3NkBp MlnHSG1UVw>? MWPJR|UxRTBwME[yJO69VQ>? MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
J.Cam 1.6 NGribJpEgXSxdH;4bYMhSXO|YYm= NUX6c417PzJiaB?= MX7EUXNQ M13u[WlEPTB;MD6xNFUh|ryP MYq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
Sup-T1 MWjDfZRwfG:6aXOgRZN{[Xl? MlzXO|IhcA>? M1zhd2ROW09? MWjJR|UxRTJwMUSyJO69VQ>? MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh5OEOzNUc,OjV6N{izN|E9N2F-
Tib 152 M4PrOmN6fG:2b4jpZ{BCe3OjeR?= MXy3NkBp NH;zdpBFVVOR NVfrcnR5UUN3ME2wMlgh|ryP NUXFSGlMRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4O|g{OzFpPkK1PFc5OzNzPD;hQi=>
MCF7 M4\PfWZ2dmO2aX;uJGF{e2G7 MVS1JO69VQ>? MknnNlQhcA>? NW[5SXVTTE2VTx?= NWC4PGRxUW6mdXPld{BIOi:PIHHydoV{fA>? NEjzSng9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUizOFQxOSd-MkW4N|Q1ODF:L3G+
MDA-MB-231 M3jvRmZ2dmO2aX;uJGF{e2G7 MVm1JO69VQ>? Mn;pNlQhcA>? M3PzNWROW09? MoHHTY5lfWOnczDHN{9OKGG{cnXzeC=> M3L6XVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEO0OFAyLz5{NUizOFQxOTxxYU6=
MCF7 NIq0e2lHfW6ldHnvckBCe3OjeR?= NVe3Tpo3PSEQvF2= MVOyOEBp NYHWOVgzTE2VTx?= NULyUGRETGWlcnXhd4V{KHSqZTDlfJBz\XO|aX;uJIxmfmWuIH;mJGNFUzFxQ1TDNi=> NX3sPG96RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4N|Q1ODFpPkK1PFM1PDBzPD;hQi=>
MCF7 M4fkNmZ2dmO2aX;uJGF{e2G7 NHXDNYY2KM7:TR?= MWqyOEBp NYHGOFY3TE2VTx?= NHjudGtF\WO{ZXHz[ZMhfGinIHX4dJJme3Orb36gcIV3\Wxib3[gR2RMOg>? MX28ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
MCF7 NFSzc2xHfW6ldHnvckBCe3OjeR?= MWq1JO69VQ>? MWiyOEBp MXPEUXNQ MXzE[YNz\WG|ZYOgeIhmKGW6cILld5Nqd25ibHX2[Ywhd2ZiY4njcIlvKEJz NF\CSYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUizOFQxOSd-MkW4N|Q1ODF:L3G+
MCF7 NILV[ZBHfW6ldHnvckBCe3OjeR?= NI\FUJg2KM7:TR?= M2naPVI1KGh? MUHEUXNQ MlPXTY5kemWjc3XzJJRp\SCneIDy[ZN{cW:wIHzleoVtKG:oIICyNUBY[WZzL1PpdFE> NIG2TnE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUizOFQxOSd-MkW4N|Q1ODF:L3G+
MCF7 NIHFTGVHfW6ldHnvckBCe3OjeR?= M2nuO|Uh|ryP MoXMNlQhcA>? NGHqVHRFVVOR NFHiNlVKdmO{ZXHz[ZMhfGinIHX4dJJme3Orb36gcIV3\Wxib3[gdFI4KEurcEG= NITl[YU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUizOFQxOSd-MkW4N|Q1ODF:L3G+
MDA-MB-231 NHjSeoRHfW6ldHnvckBCe3OjeR?= MYq1JO69VQ>? NYfTXoNuOjRiaB?= MXPEUXNQ NHHYVXpF\WO{ZXHz[ZMhfGinIHX4dJJme3Orb36gcIV3\Wxib3[gR2RMOS:FRFOy MkewQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MDA-MB-231 M1z6fGZ2dmO2aX;uJGF{e2G7 MVKxJO69VQ>? Ml7sNlQhcA>? NV;lSoR5TE2VTx?= M1G5Wmlv[3KnYYPld{B1cGViZYjwdoV{e2mxbjDs[ZZmdCCxZjDDSGsz NV3EOpVCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4N|Q1ODFpPkK1PFM1PDBzPD;hQi=>
MDA-MB-231 NEn5S4hHfW6ldHnvckBCe3OjeR?= MlHuOUDPxE1? NWLvN2d4OjRiaB?= NVzEflBOTE2VTx?= NVu3VVZ4TGWlcnXhd4V{KHSqZTDlfJBz\XO|aX;uJIxmfmWuIH;mJIN6[2yrbjDCNS=> M2LURlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEO0OFAyLz5{NUizOFQxOTxxYU6=
MDA-MB-231 M371WmZ2dmO2aX;uJGF{e2G7 MUe1JO69VQ>? NVvzXldCOjRiaB?= MWLEUXNQ Mn\oTY5kemWjc3XzJJRp\SCneIDy[ZN{cW:wIHzleoVtKG:oIICyNUBY[WZzL1PpdFE> MnL4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MDA-MB-231 M1jJOGZ2dmO2aX;uJGF{e2G7 MUK1JO69VQ>? NEi5V4MzPCCq MWLEUXNQ MlLRTY5kemWjc3XzJJRp\SCneIDy[ZN{cW:wIHzleoVtKG:oIICyO{BMcXBz NVXBW|Y{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW4N|Q1ODFpPkK1PFM1PDBzPD;hQi=>
MDA-MB-231 MXnGeY5kfGmxbjDBd5NigQ>? NI\BNmc2KM7:TR?= NFzEelkzPCCq NXzSPZh[TE2VTx?= NUTaRWt5UW6lcnXhd4V{KHSqZTDlfJBz\XO|aX;uJIxmfmWuIH;mJJA2Ow>? MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
MCF7 MmS5RZBweHSxc3nzJGF{e2G7 M{jVdlUh|ryP NU\ieYZIOjRiaB?= M{H3TmROW09? NWD1VnVvUW6mdXPld{BieG:ydH;0bYMh\GWjdHi= M1HYN|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEO0OFAyLz5{NUizOFQxOTxxYU6=
MDA-MB-231 NXXXTnlpSXCxcITvd4l{KEG|c3H5 NILoVnA2KM7:TR?= MW[yOEBp NX7ydoh{TE2VTx?= M3TLR2lv\HWlZYOgZZBweHSxdHnjJIRm[XSq MVe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTh|NESwNUc,OjV6M{S0NFE9N2F-
MCF7 MkXWSpVv[3Srb36gRZN{[Xl? MWixJO69VQ>? NYT4PJZ[PzJiaB?= MonxSG1UVw>? MoG1TY5lfWOnczDheZRweGijZ3njJIRm[XSq MniyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV6M{S0NFEoRjJ3OEO0OFAyRC:jPh?=
MDA-MB-231 NEHETYxHfW6ldHnvckBCe3OjeR?= NV;QZnNDOSEQvF2= MXq3NkBp NWfidHpMTE2VTx?= MXfJcoR2[2W|IHH1eI9xcGGpaXOg[IVifGh? M{TCXVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3OEO0OFAyLz5{NUizOFQxOTxxYU6=
U-2 OS NXrabHBQT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1jhUFUxKM7:TR?= NF[1PZAzPCCq NVvrU4V5TE2VTx?= M2[1cGlEPTB;MU[uOkDPxE1? MV:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTd7MkixNUc,OjV5OUK4NVE9N2F-
MG-63 M1[0emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NYXmbHAxPTBizszN M2Lqd|I1KGh? Mn3iSG1UVw>? NIHn[FVKSzVyPUmuOUDPxE1? NV;SXHdXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW3PVI5OTFpPkK1O|kzQDFzPD;hQi=>
U-2 OS NV7nb5RuSXCxcITvd4l{KEG|c3H5 M2H3N|Uh|ryP Ml;sNlQhcA>? NXj5W25DTE2VTx?= NFvGSJNKdmS3Y3XzJIFxd3C2b4TpZ{Bk\WyuIHTlZZRp NGXSSok9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUe5NlgyOSd-MkW3PVI5OTF:L3G+
MG-63 M4jBWmFxd3C2b4Ppd{BCe3OjeR?= M3vwT|Uh|ryP MlzhNlQhcA>? MWTEUXNQ MXfJcoR2[2W|IHHwc5B1d3SrYzDj[YxtKGSnYYTo NGDWXYU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUe5NlgyOSd-MkW3PVI5OTF:L3G+
U-2 OS NVvvW2xrTnWwY4Tpc44hSXO|YYm= MoC5OUDPxE1? MYWyOEBp MWfEUXNQ MmP2VJJwdW:2ZYOgZZV1d3CqYXfpZ{Bk\WyuIHTlZZRp NEjpSHI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUe5NlgyOSd-MkW3PVI5OTF:L3G+
MG-63 M3\hdWZ2dmO2aX;uJGF{e2G7 NVnNc41iPSEQvF2= M{DUT|I1KGh? NFf2U5dFVVOR NHLP[XZRem:vb4Tld{BifXSxcHjh[4lkKGOnbHyg[IVifGh? M{TCcVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3N{myPFEyLz5{NUe5NlgyOTxxYU6=
PANC-1 NF2xTpFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= Mn\wOVAh|ryP NWHq[WpsOjRiaB?= MojhSG1UVw>? NGrPV2lKSzVyPUeuNUDPxE1? MoDUQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4M{KyNlUoRjJ3NkOyNlI2RC:jPh?=
BxPC-3 MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4HWclUxKM7:TR?= NUXuV5dzOjRiaB?= MY\EUXNQ NXPhfpZRUUN3ME22Mlgh|ryP MonqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4M{KyNlUoRjJ3NkOyNlI2RC:jPh?=
PANC-1 MXzGeY5kfGmxbjDBd5NigQ>? Mm\qOUDPxE1? NUC1RYQ5OjRiaB?= MYrEUXNQ NH3hb|lKdmS3Y3XzJINmdGxiY4njcIUh[XK{ZYP0JIlvKEd{L12gdIhie2V? M4O1RVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkOyNlI2Lz5{NU[zNlIzPTxxYU6=
BxPC-3 M2nVN2Z2dmO2aX;uJGF{e2G7 M{\CdlUh|ryP M4LPOVI1KGh? MlLKSG1UVw>? M4\jWmlv\HWlZYOgZ4VtdCCleXPs[UBienKnc4SgbY4hTzJxTTDwbIF{\Q>? MVq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ|MkKyOUc,OjV4M{KyNlU9N2F-
PANC-1 NILRUI9HfW6ldHnvckBCe3OjeR?= M2TJW|Uh|ryP NHvYSYszPCCq M3q3dGROW09? MmrvTY5lfWOnczDheZRweGijZ3njJINmdGxiZHXheIg> MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ|MkKyOUc,OjV4M{KyNlU9N2F-
BxPC-3 Mn3kSpVv[3Srb36gRZN{[Xl? M1zsUlUh|ryP NInHUJUzPCCq M2q4bWROW09? M3H1eWlv\HWlZYOgZZV1d3CqYXfpZ{Bk\WyuIHTlZZRp MUW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ|MkKyOUc,OjV4M{KyNlU9N2F-
SKOV3 MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NILjZlQyODBizszN NX2xfpZzOjRiaB?= MnHMSG1UVw>? MXTJR|UxRTJyLkS4JO69VQ>? MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NEe1NEc,OjV4MkS3OVA9N2F-
OVCAR4 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M4L5NFExOCEQvF2= Mnr2NlQhcA>? NYntVotZTE2VTx?= M{jmb2lEPTB;MkKuNVMh|ryP NV7yRoVCRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlQ4PTBpPkK1OlI1PzVyPD;hQi=>
SKOV3 NYPDXYZyTnWwY4Tpc44hSXO|YYm= Mk[wOUDPxE1? NF71WmU4OiCq M4rlVWROW09? NYLTT25FUW6mdXPld{BIOi:PIHHydoV{fA>? NXfjOFRSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlQ4PTBpPkK1OlI1PzVyPD;hQi=>
OVCAR4 MWLGeY5kfGmxbjDBd5NigQ>? M4fTdVUh|ryP MXS3NkBp M3HYfWROW09? M1fWPWlv\HWlZYOgS|IwVSCjcoLld5Q> MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NEe1NEc,OjV4MkS3OVA9N2F-
SKOV3 MXXBdI9xfG:|aYOgRZN{[Xl? NYDJO4M{PSEQvF2= NHXRS48zPCCq NUfreXRCTE2VTx?= MU\JcoR2[2W|IHHwc5B1d3Orcx?= NIWyNHg9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[yOFc2OCd-MkW2NlQ4PTB:L3G+
OVCAR4 M{\hSmFxd3C2b4Ppd{BCe3OjeR?= M2TmfFUh|ryP M2nJXFI1KGh? NWDneHZuTE2VTx?= MVPJcoR2[2W|IHHwc5B1d3Orcx?= NGTV[YU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[yOFc2OCd-MkW2NlQ4PTB:L3G+
AGS NIDNVW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MYKyOUDPxE1? NXe4NJR[OjRiaB?= MmHRSG1UVw>? NUXIUYlHUUN3ME2xPU4xQSEQvF2= NV;PWXQ2RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NFk6OjNpPkK1OlA6QTJ|PD;hQi=>
NCI-N78 NXLzdIVqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MWWyOUDPxE1? NIiwUJczPCCq NUHVZmFDTE2VTx?= NFj0NoJKSzVyPUK2MlM{KM7:TR?= M{PBUFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkC5PVI{Lz5{NU[wPVkzOzxxYU6=
AGS MlrSRZBweHSxc3nzJGF{e2G7 MX[1JO69VQ>? MojaNlQhcA>? MUfEUXNQ M1X0emlv\HWlZYOgZZBweHSxc3nz M2Dx[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkC5PVI{Lz5{NU[wPVkzOzxxYU6=
NCI-N78 NFT1UmFCeG:ydH;zbZMhSXO|YYm= MljHOUDPxE1? NWDMXVVsOjRiaB?= NFztVmxFVVOR M1TDemlv\HWlZYOgZZBweHSxc3nz NXTlUVBvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NFk6OjNpPkK1OlA6QTJ|PD;hQi=>
AGS NVv0OYJFTnWwY4Tpc44hSXO|YYm= NV7CeGl2PSEQvF2= MViyOEBp NYmwfXFMTE2VTx?= M{HUXmlv\HWlZYOgeIhmKGG3dH;wbIFogQ>? NXLLdlR7RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NFk6OjNpPkK1OlA6QTJ|PD;hQi=>
NCI-N78 M1PUZmZ2dmO2aX;uJGF{e2G7 MXu1JO69VQ>? MVOyOEBp NULITnR4TE2VTx?= NEnTUZFKdmS3Y3XzJJRp\SCjdYTvdIhi\3l? MXO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZyOUmyN{c,OjV4MEm5NlM9N2F-
HSC-3 M{XN[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUOxJO69VQ>? NVzJcZN3PDhiaB?= NFXZO|VKSzVyPUCuOVQh|ryP NFK5TlA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NUO2OlE1Oyd-MkWzOlYyPDN:L3G+
GB30 M3nwTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXrnTFR5OSEQvF2= MUS3JIQ> NHfxVmRFVVOR MXHJR|UxRTBwMEGxJO69VQ>? NY[5R4JrRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkWxNFY1OjhpPkK1NVA3PDJ6PD;hQi=>
GB9 NVjZ[W9OT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NFjy[mEyKM7:TR?= MlP6O{Bl NX;KNYlwTE2VTx?= NHzzUFJKSzVyPUCuNFI1KM7:TR?= MXW8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTFyNkSyPEc,OjVzME[0Nlg9N2F-
GB169 M4LDN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXixJO69VQ>? NX64Z21EPyCm M2nEPWROW09? M3H1W2lEPTB;MD6wN|Ih|ryP MlHPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjVzME[0NlgoRjJ3MUC2OFI5RC:jPh?=
T24 Ml3PSpVv[3Srb36gRZN{[Xl? NYXVUWFmOSEQvF2= NVX5U21WPDhiaB?= NFP3XoZFVVOR M{eybWlv\HWlZYOgZ4VtdCCleXPs[UBienKnc4S= NIfwVGU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{SwN|Y{Oyd-MkO0NFM3OzN:L3G+
RT4 M4rDT2Z2dmO2aX;uJGF{e2G7 NGPMfGQyKM7:TR?= MonzOFghcA>? M4S2PGROW09? NEi1WphKdmS3Y3XzJINmdGxiY4njcIUh[XK{ZYP0 M1XjbFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ|NECzOlM{Lz5{M{SwN|Y{OzxxYU6=
UM-UC-3 NV\MVIdXTnWwY4Tpc44hSXO|YYm= NVLnOWM{OSEQvF2= NHrUdZg1QCCq NIfRcIZFVVOR MlXUTY5lfWOnczDj[YxtKGO7Y3zlJIFzemW|dB?= MUS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRyM{[zN{c,OjN2MEO2N|M9N2F-
T24 NUjyUYc5SXCxcITvd4l{KEG|c3H5 NXO4PWNnOy5zNjFOwG0> MofSPVYhcA>? NVGyVW0xTE2VTx?= MVXJR|UxRTBwMEOwOkDPxE1? MlvRQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MEO2N|MoRjJ|NECzOlM{RC:jPh?=
RT4 MlWwRZBweHSxc3nzJGF{e2G7 NFWxZ2k{NjF4IN88US=> MoXBPVYhcA>? NX3KUJoyTE2VTx?= NGPpfGNKSzVyPUCuNVE6QCEQvF2= Mo[wQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN2MEO2N|MoRjJ|NECzOlM{RC:jPh?=
UM-UC-3 NXvW[3dPSXCxcITvd4l{KEG|c3H5 NYLNe2RMOy5zNjFOwG0> MXO5OkBp NUniVJBzTE2VTx?= M2[xTmlEPTB;MD6wOFQ6KM7:TR?= MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzRyM{[zN{c,OjN2MEO2N|M9N2F-
OVCAR-5 MkfISpVv[3Srb36gRZN{[Xl? M4rmVlUxKG6P NETlR5VKdmirYnn0d{Bk\WyuIH3p[5JifGmxbh?= NHXlOoU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OzOFMzPyd-MkOzN|Q{Ojd:L3G+
SKOV3ip2 NYXFdXNpTnWwY4Tpc44hSXO|YYm= NVHqeFVnPTBibl2= Moj4TY5pcWKrdIOgZ4VtdCCvaXfyZZRqd25? MmizQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjN|M{SzNlcoRjJ|M{O0N|I4RC:jPh?=
S462 MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MmPINVAxKM7:TR?= MXS3NkBp M1XodmROW09? NH7ONWRCfHSnboXheIV{KGOnbHyg[5Jwf3Sq NVfwfpkxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOzNlgyOTRpPkKzN|I5OTF2PD;hQi=>
2884 MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NIruWIkyODBizszN MUi3NkBp MoLQSG1UVw>? M4f1TWF1fGWwdXH0[ZMh[2WubDDndo94fGh? NHPr[ZI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OyPFEyPCd-MkOzNlgyOTR:L3G+
2885 M3rHVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MY[xNFAh|ryP NVzvVIw5PzJiaB?= MX3EUXNQ NFLqNGtCfHSnboXheIV{KGOnbHyg[5Jwf3Sq NEPy[I49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{M{OyPFEyPCd-MkOzNlgyOTR:L3G+
CRL-2396 NY\ISXFyT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1LrUlExOCEQvF2= M4n5eJdifGW{ MmPETWM2OD1yLkC5NkDPxE1? NXLMPHhsRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkOxOVM2OjRpPkKzNVU{PTJ2PD;hQi=>
TIB-48 MomyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MoO4NVAxKM7:TR?= NX\4SHg1f2G2ZYK= NVvwfXVlUUN3ME2wMlA5QCEQvF2= MWO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF3M{WyOEc,OjNzNUO1NlQ9N2F-
CRL-2396 Mlm0R5l1d3SxeHnjJGF{e2G7 NIHvNWwyKM7:TR?= MkW4OFghcA>? NHzGcGZ4[XSnch?= M2fj[Wlv\HWlZYOgZZBweHSxc3nz MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF3M{WyOEc,OjNzNUO1NlQ9N2F-
TIB-48 MnfFR5l1d3SxeHnjJGF{e2G7 MWKxJO69VQ>? MmfjOFghcA>? NXXwfVlqf2G2ZYK= NGnSeHNKdmS3Y3XzJIFxd3C2b4Ppdy=> MWq8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOzF3M{WyOEc,OjNzNUO1NlQ9N2F-
AGS MUnDfZRwfG:6aXOgRZN{[Xl? NHLub3kxNjVizszN NHeyPJozPCCq MoLHSG1UVw>? M1e0N2Rm[3KnYYPld{Bk\WyuIIP1dpZqfmGu M{HPOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{OUeyOlEyLz5{Mkm3NlYyOTxxYU6=
FLO-1 MVPDfZRwfG:6aXOgRZN{[Xl? MVuwMlUh|ryP M1\5bFI1KGh? M1jINmROW09? MVnE[YNz\WG|ZYOgZ4VtdCC|dYL2bZZidA>? MnfYQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7N{K2NVEoRjJ{OUeyOlEyRC:jPh?=
OE33 NHrJN|hEgXSxdH;4bYMhSXO|YYm= NULlZ3ZjOC53IN88US=> M33NZ|I1KGh? NFjqXlBFVVOR NU[xdmpbTGWlcnXhd4V{KGOnbHygd5Vzfmm4YXy= MlK3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ7N{K2NVEoRjJ{OUeyOlEyRC:jPh?=
SKLMS MYrDfZRwfG:6aXOgRZN{[Xl? MXe3OUBvVQ>? MkjQPVYhcA>? M3TNXGlv\HWlZYOgZZBweHSxc3nz NXXoOZdtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NlE6QTdpPkKyPFIyQTl5PD;hQi=>
Leio285 NHTNenVEgXSxdH;4bYMhSXO|YYm= NH:x[m44PSCwTR?= MlXMPVYhcA>? NXmw[IdkUW6mdXPld{BieG:ydH;zbZM> NEXQVW49[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkiyNVk6Pyd-MkK4NlE6QTd:L3G+
Mes-Sa MVfDfZRwfG:6aXOgRZN{[Xl? MoXqO|Uhdk1? MoK2PVYhcA>? M3zlZmlv\HWlZYOgZZBweHSxc3nz NU\FRo8yRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK4NlE6QTdpPkKyPFIyQTl5PD;hQi=>
DAOY MX;DfZRwfG:6aXOgRZN{[Xl? NHHr[YEyOCEQvF2= MoP2O|IhcA>? NIDLephFVVOR MmW2TWM2OD1yLkC0JO69VQ>? NVj4VmtERGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK2Olk{OzVpPkKyOlY6OzN3PD;hQi=>
IMR32 MXzDfZRwfG:6aXOgRZN{[Xl? MljVNVAh|ryP M3S2WlczKGh? MWjEUXNQ NWe0NlZTUUN3ME2wMlA{KM7:TR?= NX;q[odiRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK2Olk{OzVpPkKyOlY6OzN3PD;hQi=>
Molt-4 NX[0TZh2S3m2b4TvfIlkKEG|c3H5 MWCxNEDPxE1? MknmO|IhcA>? MXjEUXNQ NH\TUnBKSzVyPUCuNFIh|ryP Mle4QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ4NkmzN|UoRjJ{Nk[5N|M2RC:jPh?=
MOLM-13 MnW5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUjlXpFYOyEQvF2= NVv6UJozPzJiaB?= MWXEbY1qdmm|aHXzJINmdGxidnnhZoltcXS7 MWi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjR6OEK0PUc,OjJ2OEiyOFk9N2F-
HL-60 MnXwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUmzJO69VQ>? NXPIR2NLPzJiaB?= MUHEbY1qdmm|aHXzJINmdGxidnnhZoltcXS7 MlnrQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ2OEiyOFkoRjJ{NEi4NlQ6RC:jPh?=
MV4-11 NUD2N|hVT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MXqzJO69VQ>? NGm5fGk4OiCq MUfEbY1qdmm|aHXzJINmdGxidnnhZoltcXS7 NX;qfotKRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkK0PFgzPDlpPkKyOFg5OjR7PD;hQi=>
SKM-1 NFvtfmVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NF36cYI{KM7:TR?= Ml;WO|IhcA>? MnLLSIlucW6rc3jld{Bk\WyuII\pZYJqdGm2eR?= NEXTTlE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkS4PFI1QSd-MkK0PFgzPDl:L3G+
SH2 M2nDbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MYizJO69VQ>? Mn[2O|IhcA>? M2e5dWRqdWmwaYPo[ZMh[2WubDD2bYFjcWyrdIm= MWS8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjR6OEK0PUc,OjJ2OEiyOFk9N2F-
NOMO-1 MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWqzJO69VQ>? MonOO|IhcA>? NHzzcVFFcW2rbnnzbIV{KGOnbHygeoli[mmuaYT5 M2n2[lxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{NEi4NlQ6Lz5{MkS4PFI1QTxxYU6=
OCL-AML2 Mor1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NYnZdZV4OyEQvF2= MmTBO|IhcA>? NUHBSnRLTGmvaX7pd4hmeyClZXzsJJZq[WKrbHn0fS=> MnXmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ2OEiyOFkoRjJ{NEi4NlQ6RC:jPh?=
PL-21 MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NGPDeoc{KM7:TR?= MUi3NkBp NXW5NJZxTGmvaX7pd4hmeyClZXzsJJZq[WKrbHn0fS=> MYC8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjR6OEK0PUc,OjJ2OEiyOFk9N2F-
KG-1 NI\R[3VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MkPMN{DPxE1? M3zLclczKGh? NHrYeYNFcW2rbnnzbIV{KGOnbHygeoli[mmuaYT5 NF;KdlE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkS4PFI1QSd-MkK0PFgzPDl:L3G+
A172 NW\LZ3AzS3m2b4TvfIlkKEG|c3H5 Mn\SNVAxKM7:TR?= M2HDZlI1KGh? NFnVUJNFVVOR MUHJR|UxRTBwMUKwJO69VQ>? M4S5dlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ{Mke0N|k6Lz5{MkK3OFM6QTxxYU6=
U87 MkXrR5l1d3SxeHnjJGF{e2G7 MoW2NVAxKM7:TR?= NUfuO4dvOjRiaB?= MULEUXNQ NWnwO3J3UUN3ME2wMlExPSEQvF2= MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ5NEO5PUc,OjJ{N{SzPVk9N2F-
U251 MoDQR5l1d3SxeHnjJGF{e2G7 MUGxNFAh|ryP NV7vSmVDOjRiaB?= M2XpOGROW09? MXvJR|UxRTBwMUCwJO69VQ>? MUm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ5NEO5PUc,OjJ{N{SzPVk9N2F-
T98 NHHGU2VEgXSxdH;4bYMhSXO|YYm= MmfFNVAxKM7:TR?= MXiyOEBp NH[zZZVFVVOR Mn3wTWM2OD1yLkGyOUDPxE1? NEe5VnU9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK3OFM6QSd-MkKyO|Q{QTl:L3G+
LN18 NUDJWHpQS3m2b4TvfIlkKEG|c3H5 MYCxNFAh|ryP NFz6WlczPCCq Mn\USG1UVw>? NWDlcFl1UUN3ME2wMlIyOCEQvF2= MVO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ5NEO5PUc,OjJ{N{SzPVk9N2F-
LN443 MoXUR5l1d3SxeHnjJGF{e2G7 M3;VXVExOCEQvF2= NGPNe2IzPCCq M1TQc2ROW09? NVnxclBRUUN3ME2wMlIzOCEQvF2= NW\JWoo1RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyO|Q{QTlpPkKyNlc1Ozl7PD;hQi=>
HF66 M3j1d2N6fG:2b4jpZ{BCe3OjeR?= MnrvNVAxKM7:TR?= M161U|I1KGh? MYDEUXNQ NYfiV5FEUUN3ME2wMlIzPSEQvF2= MX[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOjJ5NEO5PUc,OjJ{N{SzPVk9N2F-
HF2303 NUHw[FZKS3m2b4TvfIlkKEG|c3H5 NYPtcmJXOTByIN88US=> M2DOPVI1KGh? MXzEUXNQ NFrXNlVKSzVyPUCuNFYxKM7:TR?= NUDHZ5pXRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkKyO|Q{QTlpPkKyNlc1Ozl7PD;hQi=>
HF2359 MX7DfZRwfG:6aXOgRZN{[Xl? MXGxNFAh|ryP NYSze3Q6OjRiaB?= NHnvZ2JFVVOR NWPTWWE{UUN3ME2wMlA3OCEQvF2= NH\BWZY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MkK3OFM6QSd-MkKyO|Q{QTl:L3G+
HF2414 MnzIR5l1d3SxeHnjJGF{e2G7 NET3TmoyODBizszN NFK2clIzPCCq NXz6UI92TE2VTx?= MYHJR|UxRTBwMEiwJO69VQ>? MnL2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjJ{N{SzPVkoRjJ{Mke0N|k6RC:jPh?=
A-673 MnTVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NFjNcXAyOCEQvF2= M3L3d|k3KGh? NIL6fldFVVOR M3LrN2lEPTB;MD6wN|Ih|ryP MVu8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR2OEW5NUc,OjF2NEi1PVE9N2F-
TC-32 NWrRV3R[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NWXOWIpnOTBizszN NHX2WVE6PiCq NUfVXnhNTE2VTx?= M{na[mlEPTB;MD6wN|kh|ryP NULrUXdvRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
TC-71 NHf2WmFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NInzdpEyOCEQvF2= M1nLRlk3KGh? NIDF[mhFVVOR MVnJR|UxRTBwMUCyJO69VQ>? M2\jb|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
SK-N-MC MmfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3WzRlExKM7:TR?= MYO5OkBp NFnjZnhFVVOR MUTJR|UxRTBwMEeyJO69VQ>? MoS5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
CHLA-9 M4\vNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MlL5NVAh|ryP Ml[zPVYhcA>? MoSwSG1UVw>? MkK4TWM2OD1yLkCxPEDPxE1? NVzaNWNwRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
CHLA-10 MkPlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? Mk\0NVAh|ryP MUK5OkBp MmnzSG1UVw>? MX7JR|UxRTBwME[wJO69VQ>? M2XkOlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
CHLA-25 MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWixNEDPxE1? MXW5OkBp MWTEUXNQ NF3G[XVKSzVyPUCuNVY5KM7:TR?= NUjs[486RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
CHLA-32 NF3KNHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH3tc3QyOCEQvF2= NF3VZXI6PiCq MX3EUXNQ M{nXeGlEPTB;MD6xN|Yh|ryP M3jJfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
CHLA-56 M33aXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 M33rdFExKM7:TR?= NE\l[2U6PiCq NFj0cVhFVVOR M1i2W2lEPTB;MUCg{txO MmDmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
CHLA-258 MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NUPSV5dnOTBizszN MXS5OkBp Mn3MSG1UVw>? MV;JR|UxRTBwMUOyJO69VQ>? MX:8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR2OEW5NUc,OjF2NEi1PVE9N2F-
COG-E-352 MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NVz1foM2OTBizszN M33IOlk3KGh? MmXsSG1UVw>? NGq2cWdKSzVyPUCuNFQ{KM7:TR?= MmjDQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
CHLA-90 MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYexNEDPxE1? MYi5OkBp NYLTeWozTE2VTx?= MU\JR|UxRTBwME[xJO69VQ>? NYWzd|FTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
CHLA-119 MlnNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUOxNEDPxE1? Mn\BPVYhcA>? MV3EUXNQ NVzKZZVnUUN3ME2wMlAzOiEQvF2= MlnPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
CHLA-122 M2DPWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV3NPFQxOTBizszN NYSxUpZwQTZiaB?= MmPZSG1UVw>? NVO1N5Z5UUN3ME2wMlAyQSEQvF2= M1XMO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
CHLA-136 NHz3SpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NH3YcnoyOCEQvF2= NEnTVoE6PiCq NWjab|J4TE2VTx?= M3jvSGlEPTB;MD6wN|kh|ryP M2rRSlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
CHLA-140 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MWOxNEDPxE1? NV:5[o9ZQTZiaB?= M4LTSGROW09? M1HPS2lEPTB;MD6wNlYh|ryP M1vUXlxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
LA-N-6 M4n5UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mm\GNVAh|ryP Mor2PVYhcA>? NXTMc|hPTE2VTx?= NY\sWFY3UUN3ME2wMlA2PCEQvF2= NIPGUoE9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
NB-1643 NX\iW3ZmT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M1qwdVExKM7:TR?= MmO2PVYhcA>? Mn;SSG1UVw>? MlnQTWM2OD1yLkCzO{DPxE1? MkDzQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
NB-EBc1 M1S4emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NV;TUWRCOTBizszN NVvBb2RjQTZiaB?= MkTISG1UVw>? NUDiVoxyUUN3ME2wMlA2OCEQvF2= MkSwQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
SK-N-BE-1 NVT2VWp[T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NUfJZohSOTBizszN MlfsPVYhcA>? NWrWdVk{TE2VTx?= M3HaV2lEPTB;MD6wNlgh|ryP MlTPQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
SK-N-BE-2 NUf6fW44T3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NVvzSIdvOTBizszN Mm\GPVYhcA>? M4OwdGROW09? MlL3TWM2OD1yLkCzOkDPxE1? NYDYeWFQRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
SMS-KAN MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkW2NVAh|ryP NHrNeYU6PiCq MVjEUXNQ NUHr[IJ1UUN3ME2wMlA{PCEQvF2= M1HVTVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
SMS-KANR NEnFT3ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIrr[mwyOCEQvF2= MWG5OkBp NUTBRmVKTE2VTx?= M3rpXmlEPTB;MD6wNlYh|ryP NF\hZ5c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
SMS-KCN MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1jKS|ExKM7:TR?= NF\uT2I6PiCq NYjpelJmTE2VTx?= M3HJTmlEPTB;MD6wNVkh|ryP MWK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTR2OEW5NUc,OjF2NEi1PVE9N2F-
SMS-KCNR MkW2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? M3\Me|ExKM7:TR?= MlP1PVYhcA>? NYK0eG5TTE2VTx?= NHf6[ZFKSzVyPUCuNFExKM7:TR?= NXfFZ41ORGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkG0OFg2QTFpPkKxOFQ5PTlzPD;hQi=>
SMS-LHN MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NH;2Z48yOCEQvF2= MlH0PVYhcA>? NWGwXFQ2TE2VTx?= Mm\tTWM2OD1yLkCzNkDPxE1? M1;OfVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJzNES4OVkyLz5{MUS0PFU6OTxxYU6=
SMS-MSN Mlf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUexNEDPxE1? MorkPVYhcA>? NUPOZZhlTE2VTx?= NHLLWXdKSzVyPUCuNFIzKM7:TR?= NHXyeFk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUS0PFU6OSd-MkG0OFg2QTF:L3G+
SMS-SAN NFSwW4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NGfYe2syOCEQvF2= NXvnXoNyQTZiaB?= M3viU2ROW09? M4nNd2lEPTB;MD6wNlAh|ryP MmX2QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjF2NEi1PVEoRjJzNES4OVkyRC:jPh?=
Granta-4 MmfTR5l1d3SxeHnjJGF{e2G7 NI\MSnYyOCEQvF2= M{XEWlch\A>? NYjGdIRrUUN3ME2wMlA1OCEQvF2= NXnaNJFIRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGyPVE5PjdpPkKxNlkyQDZ5PD;hQi=>
DB NUP4PFN6S3m2b4TvfIlkKEG|c3H5 MUCxNEDPxE1? NH73V5g4KGR? NH:zOXBKSzVyPUCuNFQzKM7:TR?= MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zOTJ7MUi2O{c,OjF{OUG4Olc9N2F-
RL M2DKbGN6fG:2b4jpZ{BCe3OjeR?= M1TX[VExKM7:TR?= NGLycJE4KGR? MWLJR|UxRTBwMEG1JO69VQ>? NVLSRoY{RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkGyPVE5PjdpPkKxNlkyQDZ5PD;hQi=>
K562 NYHZXJdqT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= NX;qZ5piOTBizszN NUXV[oRwQTZiaB?= MojpTWM2OD1yLkC4O{DPxE1? NFHHbXM9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC5NVY{Oyd-MkGwPVE3OzN:L3G+
LAMA-84 M1zDdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mnf5NVAh|ryP MXS5OkBp MmS4TWM2OD1yLkC1O{DPxE1? NEXISmo9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MUC5NVY{Oyd-MkGwPVE3OzN:L3G+
MM15 M1v5cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 Mo\wOEDPxE1? MVG3NkBp MmO1SG1UVw>? NXvmbnlIUUN3ME2wMlE{KM7:TR?= NEXFN2Q9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEO4Nlg1PCd-MkCzPFI5PDR:L3G+
OPM1 MmrNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MXK0JO69VQ>? NVPuPWQ1PzJiaB?= M4LOdWROW09? NHW3WXFKSzVyPUCuNFMh|ryP NHziU249[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEO4Nlg1PCd-MkCzPFI5PDR:L3G+
RPM1 NHjGfVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NVzKN3RGPCEQvF2= NUfaeZFbPzJiaB?= NGjtUGdFVVOR MVHJR|UxRTFyLkOyJO69VQ>? NYD5dFUzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCzPFI5PDRpPkKwN|gzQDR2PD;hQi=>
INA6 MkniS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NXHR[ZoyPCEQvF2= NG\ybGc4OiCq M{XvSmROW09? NHPaT4ZKSzVyPUCuNFAzKM7:TR?= M1ntZVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyM{iyPFQ1Lz5{MEO4Nlg1PDxxYU6=
OPM2 NF7QdIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= MXu0JO69VQ>? NYW2SphMPzJiaB?= NYPjeZZFTE2VTx?= MmHUTWM2OD12LkO3JO69VQ>? M3e1TFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyM{iyPFQ1Lz5{MEO4Nlg1PDxxYU6=
MM1R MkK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MYW0JO69VQ>? Mm[1O|IhcA>? M3fQN2ROW09? MX3JR|UxRTFwNkig{txO NVLPb4s6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCzPFI5PDRpPkKwN|gzQDR2PD;hQi=>
DOX40 NFryU|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NIfYfHQ1KM7:TR?= NHLVO284OiCq NWHGN4Z7TE2VTx?= MXXJR|UxRTVwNEig{txO NWTKWXJJRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCzPFI5PDRpPkKwN|gzQDR2PD;hQi=>
LR5 MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? M1XxU|Qh|ryP Mm\FO|IhcA>? NY\EfZB[TE2VTx?= NG\lS2ZKSzVyPUKuOVMh|ryP MWe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODN6Mki0OEc,OjB|OEK4OFQ9N2F-
U266 M2jlRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 NXTkXoxEPCEQvF2= M3uxfVczKGh? MlH5SG1UVw>? MkPvTWM2OD1zLkSzJO69VQ>? NInnOGQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEO4Nlg1PCd-MkCzPFI5PDR:L3G+
RD MnvoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? MUCxNEDPxE1? MUm5OkBp MYTJR|UxRTBwMkK4JO69VQ>? MmTZQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
Rh41 NXHyeJdxT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= M4LKUlExKM7:TR?= MUS5OkBp MnrrTWM2OD1yLkC5NEDPxE1? MmnpQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
Rh30 MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MYGxNEDPxE1? M{G2bFk3KGh? M{K2VmlEPTB;MD6yN|Ah|ryP NVHIOZdSRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkCxNFg{OzhpPkKwNVA5OzN6PD;hQi=>
BT-12 NF25XGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?= NXu5SmNKOTBizszN M4jR[Fk3KGh? NGPr[oNKSzVyPUCuNFYxKM7:TR?= MXy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODFyOEOzPEc,OjBzMEizN|g9N2F-
CHLA-266 Mn[4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NV35S3FtOTBizszN MlLkPVYhcA>? M3\XfWlEPTB;MD6wO|Ih|ryP NF7ibJY9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEGwPFM{QCd-MkCxNFg{Ozh:L3G+
TC-71 MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? MkHxNVAh|ryP M2Gwd|k3KGh? MYHJR|UxRTBwMUCyJO69VQ>? NHj4R2k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEGwPFM{QCd-MkCxNFg{Ozh:L3G+
SJ-GBM2 M3PmOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MXOxNEDPxE1? M1jPSFk3KGh? M4LvWGlEPTB;MD6wOVAh|ryP M{fIWVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUC4N|M5Lz5{MEGwPFM{QDxxYU6=
NALM-6 MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NET6WmgyOCEQvF2= NFfud3Q6PiCq M1fy[mlEPTB;MD6wOlIh|ryP M{\iclxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJyMUC4N|M5Lz5{MEGwPFM{QDxxYU6=
COG-LL-317 MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? NWKweHFtOTBizszN Mni0PVYhcA>? MVHJR|UxRTBwMES3JO69VQ>? NEHXeII9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEGwPFM{QCd-MkCxNFg{Ozh:L3G+
RS4-11 MoLZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl? NUnkRpY1OTBizszN MV[5OkBp NXT1cpVXUUN3ME2wMlAyQCEQvF2= NETrcXk9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{MEGwPFM{QCd-MkCxNFg{Ozh:L3G+
MOLT-4 MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>? Mn;UNVAh|ryP M1PxeVk3KGh? M13jZ2lEPTB;MD6wNlYh|ryP MoexQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
CCRF-CEM M{O4N2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MUSxNEDPxE1? MXW5OkBp NEHuW5NKSzVyPUCuNFk1KM7:TR?= MkHqQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
Kasumi-1 NHj4VI1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?= M1vFV|ExKM7:TR?= MkO1PVYhcA>? NUDp[HFOUUN3ME2wMlExOyEQvF2= MoDyQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
Karpas-299 NYPGN2FUT3Kxd4ToJGlvcGmkaYTpc44hSXO|YYm= MYixNEDPxE1? Mm\OPVYhcA>? M3zLZmlEPTB;MD6wN|gh|ryP MnzmQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjBzMEizN|goRjJyMUC4N|M5RC:jPh?=
Ramos-RA1 M33aNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7 MnSxNVAh|ryP NYPzXZJvQTZiaB?= MUfJR|UxRTBwMUK3JO69VQ>? MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zODFyOEOzPEc,OjBzMEizN|g9N2F-
GSS MmCwRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MofLO|IhcHK| NGPrdJZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFfTV{Bk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNFM6KM7:TT6= MoXlQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkW2NVcoRjJ3NkK1OlE4RC:jPh?=
LU99A MkfuRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? NY\TSpo4PzJiaILz MoDNRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCOVUm5RUBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNFYzKM7:TT6= NXLzeldxRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlU3OTdpPkK1OlI2PjF5PD;hQi=>
HL60 NWHl[WVTSW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= NWjyXWRiPzJiaILz NHjKfmpCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjMOlAh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IGfTWFgh[XO|YYmsJGlEPTBiPTCwMlA4PCEQvF2u M3TVRVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkK1OlE4Lz5{NU[yOVYyPzxxYU6=
LC2/ad MUjBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M4TlWlczKGi{cx?= MVXBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEyFMj;h[EBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNFc4KM7:TT6= NYjIcGlzRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlU3OTdpPkK1OlI2PjF5PD;hQi=>
MKN45 MYDBcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? NXHJNY44PzJiaILz NVzTPYFYSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNT241PSClZXzsd{Bi\nSncjC3NkBpenNiYomgW3NVQCCjc4PhfUwhUUN3MDC9JFAvODl|IN88UU4> MYO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NU[xO{c,OjV4MkW2NVc9N2F-
HCT116 MlfiRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MlTsO|IhcHK| MXfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKEiFVEGxOkBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuNFk2KM7:TT6= M4DOeFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ3NkK1OlE4Lz5{NU[yOVYyPzxxYU6=
Lu116 M2fndGFvfGmycn;sbYZmemG2aY\lJIF{e2G7 Mn;4O|IhcHK| NHi2eHRCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFz1NVE3KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDXV3Q5KGG|c3H5MEBKSzVyIE2gNE4xQTdizszNMi=> MYm8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPTZ{NU[xO{c,OjV4MkW2NVc9N2F-
NCI-H358 M17l[GFvfGmycn;sbYZmemG2aY\lJIF{e2G7 MV[3NkBpenN? MX\BcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE6FST3IN|U5KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDXV3Q5KGG|c3H5MEBKSzVyIE2gNE4yKM7:TT6= NWDFXW9CRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkW2NlU3OTdpPkK1OlI2PjF5PD;hQi=>
MIAPaCa2 MlnmRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? MnTsO|IhcHK| NXH2N|gxSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNTWFR[UOjMjDj[YxteyCjZoTldkA4OiCqcoOgZpkhX1OWODDhd5NigSxiSVO1NEA:KDBwMUOg{txONg>? Mnu1QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkW2NVcoRjJ3NkK1OlE4RC:jPh?=
PC14 MmrsRY51cXC{b3zp[oVz[XSrdnWgZZN{[Xl? M3H2SlczKGi{cx?= NG\rUHpCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDNVQh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IGfTWFgh[XO|YYmsJGlEPTBiPTCwMlE4KM7:TT6= NGrLS4w9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[yOVYyPyd-MkW2NlU3OTd:L3G+
HT-29 NV\IW3g4SW62aYDyc4xq\mW{YYTpeoUh[XO|YYm= Mo\5O|IhcHK| MnPLRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6|dDDoeY1idiCKVD2yPUBk\WyuczDh[pRmeiB5MjDodpMh[nliV2PUPEBie3OjeTygTWM2OCB;IECuN|Mh|ryPLh?= NHTOS3c9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NU[yOVYyPyd-MkW2NlU3OTd:L3G+
HCT15 MX\BcpRqeHKxbHnm[ZJifGm4ZTDhd5NigQ>? M3G3fVczKGi{cx?= NYfKZlJqSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIR3QyPSClZXzsd{Bi\nSncjC3NkBpenNiYomgW3NVQCCjc4PhfUwhUUN3MDC9JFAvPzRizszNMi=> MmjVQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjV4MkW2NVcoRjJ3NkK1OlE4RC:jPh?=
Sf9 MYjGeY5kfGmxbjDhd5NigQ>? NVH3ZVFVS2:vcHX0bZRqfmViaX7obYJqfGmxbjDv[kBz\WOxbXLpcoFvfCCvb4Xz[UBifXKxcnGgb4lv[XOnIFGg[ZhxemW|c3XkJIlvKGmwc3XjeEBU\jliY3XscJMhcW5icILld4Vv[2Vib3[gRXRRNCCNaTC9JFAvODByMzFOwG0v M1izO|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ4MUCxOVY1Lz5{NkGwNVU3PDxxYU6=
Sf9 Mof0SpVv[3Srb36gZZN{[Xl? M3jHWmlvcGmkaYTpc44hd2ZicnXjc41jcW6jboSgcY92e2ViYYXyc5JiKGurbnHz[UBCKGW6cILld5Nm\CCrbjDpcpNm[3RiU3[5JINmdGy|IIXzbY5oKGKrb4Tpck1IVFKUQWPMS{BieyC|dXLzeJJifGViaX6gdJJme2WwY3Wgc4YhY2ejbX3hMVM{WF2DVGCsJGlEPTBiPTCwMlAxOSEQvF2u NYrpTYFtRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMk[xNFE2PjRpPkK2NVAyPTZ2PD;hQi=>
HCT116 MVXGeY5kfGmxbjDhd5NigQ>? NV:zZpVEUW6qaXLpeIlwdiCxZjDheZJwemFia3nuZZNmKEFiYYX0c5Bpd3OyaH;yfYxifGmxbjDheEBVOjh6IHnuJIh2dWGwIFjDWFEyPiClZXzsd{BjgSCrbX31co9ndHWxcnXzZ4Vv[2ViYX7hcJl{cXNuIFnDOVAhRSByLkCwO{DPxE1w MVi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjFyMUW2OEc,OjZzMEG1OlQ9N2F-
HCT116 M3fJ[mN6fG:2b4jpZ4l1gSCjc4PhfS=> MUPDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDIR3QyOTZiY3XscJMh[XO|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBk\WyuIIDyc4xq\mW{YYTpc44h[nliQoLkWUBqdmOxcoDvdoF1cW:wIHHzd4F6NCCJSUWwJF0hOC5yMzFOwG0v MXe8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjFyMUW2OEc,OjZzMEG1OlQ9N2F-
HCT116 M{D1WWZ2dmO2aX;uJIF{e2G7 NXzC[FJGUW6qaXLpeIlwdiCxZjDheZJwemFia3nuZZNmKEJiaX6gbJVu[W5iSFPUNVE3KGOnbHzzJIF{e2W|c3XkJIF{KGmwaHnibZRqd25ib3[gbIl{fG:wZTDIN{BxcG:|cHjvdplt[XSrb36gZpkhcW2vdX7v[ox2d3Knc3PlcoNmKGGwYXz5d4l{NCCLQ{WwJF0hOS53IN88UU4> NHrjNlI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{NkGwNVU3PCd-Mk[xNFE2PjR:L3G+
BL21 (DE3) Rosetta MlTmSpVv[3Srb36gZZN{[Xl? NFG1Z|Q{OCCvaX7z NFvVUYFKdmirYnn0bY9vKG:oIFjpd{11[WepZXSgbJVu[W5iQYXyc5JiKEFia3nuZZNmKChzMkKgeI8hPDBicnXzbYR2\XNrIHX4dJJme3OnZDDpckBGe2OqZYLpZ4hq[SClb3zpJGJNOjFiKFTFN{khWm:|ZYT0ZUBk\WyuczD1d4lv\yCkaX;0bY56dGG2ZXSgV3RMOiC|dXLzeJJifGViaX7jeYJifGWmIH\vdkA{OCCvaX7zJIJ6KEiWUl[gZZN{[XluIFnDOVAhRSByLkCwNFA1KM7:TT6= M1G3VFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ5M{mxNVM{Lz5{N{O5NVE{OzxxYU6=
HeLa Kyoto NI\NPHVHfW6ldHnvckBie3OjeR?= NGjESpEzOCCqcoO= M{XhWWlvcGmkaYTpc44hd2ZiQYXyc5JiKEJia3nuZZNmKGmwIHj1cYFvKEinTHGgT5lwfG9iY3XscJMh[XO|ZYPz[YQh[XNiZX\m[YN1KG:wIHTpd5RzcWK3dHnvckBw\iCyaIPwbI8ucGm|dH;u[UBJOyC|ZYKxNEBt\X[nbDDpcoN2[mG2ZXSg[o9zKDJyIHjyd{whUUN3MDC9JFAvODBzNTFOwG0v NEi2bXI9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{N{O5NVE{Oyd-MkezPVEyOzN:L3G+
HeLa Kyoto NEjo[XhHfW6ldHnvckBie3OjeR?= M4\tSFIxKGi{cx?= MV;Jcohq[mm2aX;uJI9nKEG3cn;yZUBCKGurbnHz[UBifXSxcHjvd5Bpd3K7bHH0bY9vKGG2IGTodlI5QCCrbjDoeY1idiCKZVzhJGt6d3SxIHPlcIx{KGmwY4XiZZRm\CCob4KgNlAhcHK|LDDJR|UxKD1iMD6wNFY4KM7:TT6= Mn3QQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd|OUGxN|MoRjJ5M{mxNVM{RC:jPh?=
multiple myeloma MlHqSpVv[3Srb36gZZN{[Xl? NULvNXpMW3WycILld5Nqd25ib3[gZ4VtdCCvaYTvd4l{KGmwIHj1cYFvKG23bITpdIxmKG27ZXzvcYEh[2WubIOsJGlEPTBiPTCwMlAxOyEQvF2u M3flSFxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ6OUG4NFk3Lz5{OEmxPFA6PjxxYU6=
Calu6 M{jP[mFvfGm2dX3vdkBie3OjeR?= MmfoNlAhdWdxa3e= NELuWWwzOSCmYYnz MXXBcpRqfHWvb4KgZYN1cX[rdImgZYdicW6|dDDoeY1idiCFYXz1OkBk\WyuczD4[Y5w\3KjZoTl[EBqdiCvb4Xz[UBie3Onc4Pl[EBieyC2dX3vdkBoem:5dHigbY5pcWKrdHnvckBifCB{MDDt[{9s\yxicH:gZollKGGmbXnubZN1\XKnZDDmc5IhOjFiZHH5dy=> MXi8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zPjFyMUW2OEc,OjZzMEG1OlQ9N2F-
HeLa Kyoto M3;LV2Z2dmO2aX;uJIF{e2G7 NVrKd|JbOC5{NTD1US=> M1jU[VIxKGi{cx?= M3npVGlvcGmkaYTpc44hd2ZiQYXyc5JiKEFia3nuZZNmKGyxY3HsbZpifGmxbjDheEB{eGmwZHzlJI1q[3KxdIXieYxmeyCrbjDoeY1idiCKZVzhJGt6d3SxIHPlcIx{KGG2IECuNlUhfU1iaX7jeYJifGWmIH\vdkAzOCCqcoO= MnXiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjd|OUGxN|MoRjJ5M{mxNVM{RC:jPh?=
MDA-MB-231 NEPUcG5HfW6ldHnvckBie3OjeR?= NH\1TFQyKHWP NFPKem81QCCqcoO= M2HTcGlv\HWldHnvckBw\iClaILvcY9{d22nIHHsbYdvdWWwdDDk[YZm[3S|IHnuJIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYYSgNUB2VSCjZoTldkA1QCCqcoOgZpkhTEGSSTDzeIFqdmmwZzDiZZNm\CCrbX31co9ndHWxcnXzZ4Vv[2ViYYPzZZk> MUO8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTN3OEG0O{c,Ojl|NUixOFc9N2F-
MDA-MB-231 M4\iO2Z2dmO2aX;uJIF{e2G7 Mon6NUB2VQ>? M1S0XlQ5KGi{cx?= MVrJcoR2[3Srb36gc4Yh[WKncoLhcpQhe3CrbnTs[UBnd3KvYYTpc44hf2m2aDD0dolxd2yjcjDhcoQhfGW2cnHwc4xieiCxY3P1dpJmdmOnIHnuJIh2dWGwIF3ERU1OSi1{M{GgZ4VtdHNiYYSgNUB2VSCjZoTldkA1QCCqcoOgZpkhTEGSSTDzeIFqdmmwZzDiZZNm\CCrbX31co9ndHWxcnXzZ4Vv[2ViYYPzZZk> NYT4RWJTRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkmzOVgyPDdpPkK5N|U5OTR5PD;hQi=>
MDA-MB-231 MlTiSpVv[3Srb36gZZN{[Xl? MknJNE42KHWP MX60PEBpenN? M3LQbGlvcGmkaYTpc44hd2ZiYXzwbIEufHWkdXzpckBqdiCqdX3hckBOTEFvTVKtNlMyKGOnbHzzJIF{e2W|c3XkJIF{KGGkb3zpd4hu\W62IH;mJJJm\3WuYYKgcI9k[XSrb36gc4YheHKxdHXpckBifCByLkWgeW0h[W[2ZYKgOFghcHK|IHL5JGRCWElic4ThbY5qdmdiYnHz[YQhcW2vdX7v[ox2d3Knc3PlcoNmKGG|c3H5 MoL3QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl|NUixOFcoRjJ7M{W4NVQ4RC:jPh?=
MDA-MB-231 NWLZVm1STnWwY4Tpc44h[XO|YYm= NE\xUnYxNjVidV2= NWjKcJVvPDhiaILz NFjmTohKdmirYnn0bY9vKG:oIFHVVmtCKGmwIHj1cYFvKE2GQT3NRk0zOzFiY3XscJMh[XO|ZYPz[YQh[XNiYXLvcIl{cG2nboSgc4YhemWpdXzhdkBtd2OjdHnvckBw\iCycn;0[YlvKGG2IECuOUB2VSCjZoTldkA1QCCqcoOgZpkhTEGSSTDzeIFqdmmwZzDiZZNm\CCrbX31co9ndHWxcnXzZ4Vv[2ViYYPzZZk> NFvuXnA9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUO1PFE1Pyd-MkmzOVgyPDd:L3G+
TC32 MYPxTHRUKGG|c3H5 MX;xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhXEN|MjDj[Yxtew>? NYHobXBNRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
Saos-2 NXHJdJlSeUiWUzDhd5NigQ>? NGr1U|FyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiU3Hvd{0zKGOnbHzz M{TlPVxiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
SK-N-SH NE\iXGZyUFSVIHHzd4F6 NXfPZ253eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uW0hiY3XscJM> NVPYN2xYRGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
MG 63 (6-TG R) NG\pUVdyUFSVIHHzd4F6 MY\xTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhVUdiNkOgLFYuXEdiUjmgZ4VtdHN? M1HVS|xiKHSjcnfleF0oZ2KuYX7rK{BpemWoPTfoeJRxezpxL4D1Zo1m\C6wY3LpMo5tdS6waXiu[493NzJ7NEO1NVM6Lz5{OUSzOVE{QTxxYU6=
NB1643 NGPqUJJyUFSVIHHzd4F6 MkH1dWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKE6EMU[0N{Bk\Wyucx?= NFrFc3k9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
NB-EBc1 MWXxTHRUKGG|c3H5 NVjSVWVCeUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhVkJvRVLjNUBk\Wyucx?= Mm\yQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
MG 63 (6-TG R) MYnxTHRUKGG|c3H5 NYH4N3JleUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiQ3;u[olzdWG2b4L5JJNkemWnbjDmc5IhVUdiNkOgLFYuXEdiUjmgZ4VtdHN? NVrZfJo6RGFidHHy[4V1RSehYnzhcosoKGi{ZX[9K4h1fHC|Oj:vdJVjdWWmLn7jZokvdmyvLn7pbE5od3ZxMkm0N|UyOzlpPkK5OFM2OTN7PD;hQi=>
U-2 OS MYjxTHRUKGG|c3H5 M2rXOJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHUuOiCRUzDj[Yxtew>? MXK8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
SJ-GBM2 M3;PdJFJXFNiYYPzZZk> MVPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBRemmvYYL5JJNkemWnbjDmc5IhW0pvR1LNNkBk\Wyucx?= MoDJQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC M4jhXpFJXFNiYYPzZZk> NYPCWno1eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IGPLMW4uVUNiY3XscJM> MoTiQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
NB-EBc1 NGHaVlVyUFSVIHHzd4F6 NY\UfI55eUiWUzDv[kBx\WSrYYTybYMh[2GwY3XyJINmdGxibHnu[ZMhfG9iaXTlcpRq\nlibYXseIlxdGVib4Dwc5J1fW6rdHnld{Bnd3JiZIL1[{Bz\XC3coDvd4lv\zpiUILpcYFzgSC|Y4Ll[Y4h\m:{IF7CMWVD[zFiY3XscJM> NFvBTXQ9[SC2YYLn[ZQ:L1:kbHHub{chcHKnZk2nbJR1eHN8Lz;weYJu\WRwbnPibU5vdG1wbnnoModwfi9{OUSzOVE{QSd-Mkm0N|UyOzl:L3G+
LAN-5 M2DkdpFJXFNiYYPzZZk> Mn\ZdWhVWyCxZjDw[YRq[XS{aXOgZ4Fv[2W{IHPlcIwhdGmwZYOgeI8hcWSnboTp[pkhdXWudHnwcIUhd3Cyb4L0eY5qfGmnczDmc5Ih\HK3ZzDy[ZB2enCxc3nu[|ohWHKrbXHyfUB{[3KnZX6g[o9zKEyDTj21JINmdGy| MY[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Rh18 MX7xTHRUKGG|c3H5 NIiwZpRyUFSVIH;mJJBm\GmjdILpZ{Bk[W6lZYKgZ4VtdCCuaX7ld{B1dyCrZHXueIlngSCvdXz0bZBt\SCxcIDvdpR2dmm2aXXzJIZweiCmcoXnJJJmeHW{cH;zbY5oQiCScnntZZJ6KHOlcnXlckBnd3JiUnixPEBk\Wyucx?= Ml3vQIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
SK-N-MC M2\WSpFJXFNiYYPzZZk> MWPxTHRUKG:oIIDl[IlifHKrYzDjZY5k\XJiY3XscEBtcW6nczD0c{Bq\GWwdHnmfUBufWy2aYDs[UBweHCxcoT1col1cWW|IH\vdkBlenWpIILldJVzeG:|aX7nPkBEd26oaYLtZZRwenlic3Py[YVvKG[xcjDTT{1PNU2FIHPlcIx{ MmX5QIEhfGG{Z3X0QUdg[myjbnunJIhz\WZ;J3j0eJB{Qi9xcIXicYVlNm6lYnmucoxuNm6raD7nc5YwOjl2M{WxN|koRjJ7NEO1NVM6RC:jPh?=
TC32 M3TCS5FJXFNiYYPzZZk> M{DibJFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHREOzJiY3XscJM> MVy8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-
Saos-2 NGjzd5dyUFSVIHHzd4F6 M1XzRpFJXFNib3[gdIVlcWG2cnnjJINidmOncjDj[YxtKGyrbnXzJJRwKGmmZX70bYZ6KG23bITpdIxmKG:ycH;yeJVvcXSrZYOg[o9zKGS{dXegdoVxfXKyb4Ppcoc7KEOxbn\pdo1ifG:{eTDzZ5Jm\W5iZn;yJHNid3NvMjDj[Yxtew>? MV[8ZUB1[XKpZYS9K39jdGGwazegbJJm\j1paIT0dJM7Ny:ydXLt[YQvdmOkaT7ucI0vdmmqLnfvek8zQTR|NUGzPUc,Ojl2M{WxN|k9N2F-

... Click to View More Cell Line Experimental Data

Assay
Methods Test Index PMID
Western blot
p-AURKA(T288) / p-EIF4E(S209) / c-Myc; 

PubMed: 28073841     


Inhibition of AURKA with alisertib downregulated p-EIF4E (S209) and c-MYC protein levels as assayed by Western blotting.

phospho-Aurora A / Aurora B; 

PubMed: 22863010     


MLN8237differentially inhibited phosphorylation of Aurora kinases. CMK cells were incubated with 0.1 µM paclitaxel for 18 hr, then DMSO or MLN8237 was added and incubated for 2 hr. The degree of phosphorylation of the Aurora kinases in each sample was determined by Western blot.

H3S10P / H3K27me2 / H3K27me3 / H3K9me2 / H3AcK / H4K16Ac; 

PubMed: 29477140     


THP-1 cells were treated with alisertib or DMSO for 48 h. The levels of histone modifications were detected by western blot analysis with the indicated antibodies. H3 was used as a loading control.

28073841 22863010 29477140
Growth inhibition assay
Cell viability; 

PubMed: 25632225     


PANC-1 and BxPC-3 cells were treated with ALS at concentrations ranging from 0.1 μM to 50 μM for 24 hours. The viability of PANC-1 and BxPC-3 cells determined by MTT assay. ALS, alisertib.

25632225
Immunofluorescence
acetylated α-tubulin / γ-tubulin; 

PubMed: 29401581     


Representative immunofluorescence (IF) image and graph in human PKD1-mutant WT9-7, WT9-12 cells or hTERT-RPE1 (RPE1) cells after 2 hours treatment with vehicle, ganetespib , or alisertib to inhibit AURKA, or combination of alisertib and ganetespib. acetylated α-tubulin (red); γ-tubulin (green); DAPI (blue). Scale bars, 5 μm.

E-cadherin / β-catenin / vimentin / p-SMAD5; 

PubMed: 23334326     


Immunofluorescence analysis of CD24 (-/low) cells treated with1 μM MLN8237 for 48 and 72 h showing reversion of EMT. E-cadherin and p-SMAD5 were labeled in red, β-catenin and vimentin were labeled in green, and DNA was labeled in blue with Hoechst dye.

Centrin-2 / tubulin; 

PubMed: 30899434     


Following inhibition of Aurora A kinase activity with 100 nM alisertib, cells with two or excess centrosomes similarly exhibit disorganized mitotic spindles. Cells with extra centrosomes are efficiently clustered into bipolar spindles prior to anaphase onset while those with supernumerary centrosomes undergo multipolar mitoses. Centrin-2, a marker of centrioles is shown in green, tubulin in red, and chromatin in blue. AurA inhibitor: alisertib.

phospho-Aurora A(T288); 

PubMed: 20382844     


MM1.S cells were treated with DMSO or MLN8237 (0.5μM) for 24 hours and then stained with anti-phospho (Thr288)-Aurora-A kinase antibody (red), αtubulin (green), and DNA (blue). Overlapping localization is shown in the merged images. Arrow indicates Aurora-A autophosphorylation on Thr288 in the centrosome (original magnification ×40). Magnified single mitotic cell image is shown in the right panel. 

29401581 23334326 30899434 20382844
In vivo MLN8237 significantly reduces the tumor burden with tumor growth inhibition (TGI) of 42% and 80% at 15 mg/kg and 30 mg/kg, respectively, and prolongs the survival of mice compared with the control. [2]

Protocol

Kinase Assay:[1]
- Collapse

Aurora A radioactive Flashplate enzyme assay:

Aurora A radioactive Flashplate enzyme assay is conducted to determine the nature and degree of MLN8237-mediated inhibition in vitro. Recombinant Aurora A is expressed in Sf9 cells and purified with GST affinity chromatography. The peptide substrate for Aurora A is conjugated with biotin (Biotin-GLRRASLG). Aurora A kinase (5 nM) is assayed in 50 mM Hepes (pH 7.5), 10 mM MgCl2, 5 mM DTT, 0.05% Tween 20, 2 μM peptide substrate, 3.3 μCi/mL [γ-33P]ATP at 2 μM, and increasing concentrations of MLN8237 by using Image FlashPlates.
Cell Research:[2]
- Collapse
  • Cell lines: MM1.S, MM.1R, LR5, RPMI 8226, DOX40, OPM1, OPM2, INA6, and U266
  • Concentrations: Dissolved in DMSO, final concentrations ~10 μM
  • Incubation Time: 24, 48, and 72 hours
  • Method: Cells are exposed to various concentrations of MLN8237 for 24, 48, and 72 hours. Cells viability is measured using MTT assay, and cell proliferation is measured using 3[H]-thymidine incorporation. For cell cycle analysis, cells are permeabilized by 70% ethanol at -20 °C, and incubated with 50 μg/mL PI and 20 units/mL RNase-A. DNA content is analyzed by flow cytometry using BDFACS-Canto II and FlowJo software. For the detection of apoptosis and senescence, cells are stained with fluorescein isothiocyanate-annexin V and PI. Apoptotic cells are determined by flow cytometric analysis using BDFACS-Canto II and FlowJo software.
    (Only for Reference)
Animal Research:[2]
- Collapse
  • Animal Models: Severe combined immune-deficient (SCID) mice inoculated subcutaneously with MM1.S cells
  • Dosages: ~30 mg/kg/day
  • Administration: Orally
    (Only for Reference)

Solubility (25°C)

In vitro DMSO 27 mg/mL (52.03 mM)
Water Insoluble
Ethanol Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5%DMSO+30% PEG300+5%Tween-80+ddH2O
For best results, use promptly after mixing.
6mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 518.92
Formula

C27H20ClFN4O4

CAS No. 1028486-01-2
Storage powder
in solvent
Synonyms N/A
Smiles COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Dosage mg/kg Average weight of animals g Dosing volume per animal ul Number of animals
Step 2: Enter the in vivo formulation ()
% DMSO % % Tween 80 % ddH2O
CalculateReset

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04479306 Recruiting Drug: Alisertib|Drug: Osimertinib|Drug: Sapanisertib Recurrent Lung Non-Small Cell Carcinoma|Stage IIIB Lung Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8 M.D. Anderson Cancer Center June 18 2020 Phase 1
NCT02812056 Withdrawn Drug: Alisertib|Drug: TAK-228 Malignant Neoplasms of Digestive Organs|Malignant Neoplasms of Female Genital Organs|Malignant Neoplasms of Lip Oral Cavity and Pharynx|Malignant Neoplasms of Male Genital Organs M.D. Anderson Cancer Center|Millennium Pharmaceuticals Inc. September 2016 Phase 1
NCT02719691 Active not recruiting Drug: Alisertib|Drug: MLN0128 Metastatic Breast Cancer|Solid Tumors University of Colorado Denver May 13 2016 Phase 1
NCT02367352 Terminated Drug: Alisertib|Drug: Paclitaxel Advanced Solid Tumors|Ovarian Cancer|Small Cell Lung Cancer Millennium Pharmaceuticals Inc.|Takeda March 19 2015 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Frequently Asked Questions

  • Question 1:

    What is the suggested formulation of this compound for mouse injection(i.p.)?

  • Answer:

    It can be dissolved in 6% DMSO/50% PEG 300/5% Tween 80/ddH2O at 10 mg/ml as a clear solution.

Aurora Kinase Signaling Pathway Map

Aurora Kinase Inhibitors with Unique Features

Related Aurora Kinase Products

Tags: buy Alisertib (MLN8237) | Alisertib (MLN8237) supplier | purchase Alisertib (MLN8237) | Alisertib (MLN8237) cost | Alisertib (MLN8237) manufacturer | order Alisertib (MLN8237) | Alisertib (MLN8237) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID